Comprehensive medication guide to Valtrex including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0–$30 copay for generic valacyclovir on most commercial and Medicare Part D plans (Tier 1–2). Brand Valtrex may require prior authorization or step therapy through the generic first.
Estimated Cash Pricing
$69–$208 retail for generic valacyclovir (30 x 500 mg tablets); as low as $11–$17 with GoodRx or SingleCare coupons. Brand Valtrex retails for $472–$512 without insurance.
Medfinder Findability Score
78/100
Summarize with AI
On this page
Valtrex is a brand-name prescription antiviral medication. Its generic name is valacyclovir, and it is manufactured by GlaxoSmithKline. FDA-approved in December 1995, it has become one of the most widely prescribed medications in the United States — with over 7 million prescriptions filled annually as of 2023.
Valtrex is used to treat infections caused by herpes viruses, including cold sores (herpes labialis), genital herpes (herpes simplex), and shingles (herpes zoster). It is also approved for chickenpox in children ages 2 and older. An important note: Valtrex does not cure herpes. The virus remains dormant in the body between outbreaks, but Valtrex reduces the severity, duration, and frequency of outbreaks.
Generic valacyclovir is therapeutically identical to brand-name Valtrex and is available from multiple manufacturers. Generic versions have been available since 2007 and are significantly more affordable, making valacyclovir accessible for most patients.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Valtrex (valacyclovir) is a prodrug — meaning it is inactive when swallowed and must be converted by the body to become active. After you take a valacyclovir tablet, enzymes in the intestinal wall and liver convert it into acyclovir, the active antiviral compound. This prodrug design gives valacyclovir a major advantage: approximately 54% bioavailability, compared to only about 12% for oral acyclovir taken directly.
Once acyclovir enters herpes-infected cells, it is activated by viral thymidine kinase — an enzyme produced only by the herpes virus. The activated acyclovir then mimics a natural DNA building block and is incorporated into the virus's growing DNA chain. This terminates the chain, permanently blocking the virus from replicating. Because the activation step requires the viral enzyme, acyclovir accumulates primarily in infected cells, giving valacyclovir a targeted safety profile.
Valtrex only works on actively replicating virus. This is why starting treatment at the first sign of symptoms — before visible lesions appear — is critical. For shingles, treatment must start within 72 hours of rash onset for maximum effectiveness.
500 mg — tablet
Most common strength; used for suppressive therapy (500 mg once daily) and recurrent genital herpes episodic treatment (500 mg twice daily for 3 days)
1,000 mg (1 g) — tablet
Used for shingles (1 g three times daily for 7 days), initial genital herpes (1 g twice daily for 10 days), and cold sores (2 g twice in one day)
Valtrex (valacyclovir) is not in a formal FDA shortage as of 2026, but local pharmacy stockouts do occur. With over 7 million prescriptions written annually and rising telehealth-driven demand, high-volume pharmacies can temporarily run out before their next restock. These stockouts typically resolve within 1–3 business days.
If your pharmacy is out of stock, use medfinder to quickly identify which pharmacies near you currently have valacyclovir available. medfinder calls pharmacies on your behalf and texts you the results — saving you the frustration of sitting on hold at multiple locations.
Tips to improve your chances of finding Valtrex in stock: try independent pharmacies (they often use different distributors than chains), ask about both the 500 mg and 1 g strengths, request a special order for 1–2 day delivery, or consider a mail-order pharmacy for suppressive therapy. The generic (valacyclovir) is generally more widely stocked than brand-name Valtrex.
Valtrex (valacyclovir) is not a controlled substance and has no special DEA prescribing requirements. Any licensed prescriber in the United States can prescribe it, including physicians, nurse practitioners, and physician assistants.
Primary care physicians (PCPs) — most common prescribers
Infectious disease specialists — for complex or immunocompromised cases
Dermatologists — for shingles and recurrent cold sores
OB/GYNs — for genital herpes management during pregnancy
Nurse practitioners (NPs) and physician assistants (PAs) — can prescribe independently in most states
Urgent care providers — for acute presentations (new shingles rash, first cold sore)
Telehealth is widely available for valacyclovir prescriptions. Platforms including Wisp, Ro (Roman/Rory), Hims & Hers, Everlywell, and CallonDoc can evaluate symptoms and send prescriptions to your pharmacy the same day, in all 50 states.
No. Valtrex (valacyclovir) is not a controlled substance. It is not listed on the DEA's Controlled Substances schedules (Schedules I through V). This means there are no special prescribing restrictions — any licensed prescriber can write a prescription for valacyclovir, including via telehealth in all 50 states.
Because valacyclovir is not a controlled substance, prescriptions can be sent electronically, called in, or faxed without restriction. There are no limits on refills based on scheduling, and no special DEA registration is required by the prescriber. This makes it one of the more accessible prescription medications, particularly through telehealth platforms.
Most patients tolerate valacyclovir well. Common side effects are generally mild:
Headache (most common)
Nausea
Vomiting
Diarrhea
Dizziness
Abdominal pain
Serious side effects (seek immediate medical care if any occur):
Kidney damage — signs: decreased urination, swelling, fatigue, confusion
CNS effects — signs: agitation, confusion, hallucinations, seizures (especially in elderly or patients with kidney disease)
TTP/HUS (rare, mainly immunocompromised patients) — signs: fever, bruising, bloody diarrhea, jaundice
Severe allergic reaction — signs: hives, difficulty breathing, facial swelling
Know what you need? Skip the search.
Acyclovir (Zovirax)
The original antiviral prodrug that valacyclovir converts into. Same clinical outcomes at equivalent doses, but requires up to 5x daily dosing vs. valacyclovir's 2-3x. Available as generic, oral, IV, and topical forms. Often less expensive than valacyclovir.
Famciclovir (Famvir)
A prodrug of penciclovir; treats shingles, recurrent genital herpes, and cold sores. Not approved for initial-episode genital herpes. Similar dosing frequency to valacyclovir but sometimes harder to find at pharmacies due to lower prescribing volume.
Penciclovir (Denavir)
Topical antiviral cream for cold sores (herpes labialis) only. Not appropriate for genital herpes or shingles. Less convenient than single-day oral valacyclovir for cold sores.
Prefer Valtrex? We can find it.
Acyclovir
majorDo not combine — valacyclovir converts to acyclovir in the body. Concurrent use doubles acyclovir exposure and significantly increases kidney toxicity and CNS side effect risk.
Imipenem/cilastatin
majorMay increase seizure risk through unknown mechanism. Avoid concurrent use unless benefit outweighs risk.
NSAIDs (ibuprofen, naproxen)
moderateAdditive nephrotoxicity risk — both impair kidney function. Avoid concurrent use; consider acetaminophen instead.
Probenecid
moderateReduces renal clearance of acyclovir, causing blood levels to build up. Dose adjustment may be required.
Tenofovir-based HIV antivirals
moderateAdditive nephrotoxicity. Both drugs compete for renal tubular elimination. Monitor kidney function closely.
Cimetidine (Tagamet)
minorIncreases valacyclovir levels by decreasing renal clearance. Less common with modern acid reducers like omeprazole.
Talimogene laherparepvec (T-VEC)
majorValacyclovir may reduce effectiveness of T-VEC cancer therapy by suppressing the herpes virus the drug relies on.
Valtrex (valacyclovir) is one of the most effective and widely prescribed antivirals in the world for managing herpes virus infections. With a 25+ year safety record, FDA approval for six indications, and generic availability that makes it highly affordable, it remains the first-line treatment for cold sores, genital herpes, and shingles in 2026.
The most important things to remember: start treatment early (timing is everything with antivirals), stay well hydrated while taking it, and use generic valacyclovir with a discount card to dramatically reduce your out-of-pocket cost. Generic valacyclovir is therapeutically identical to brand Valtrex at a fraction of the price.
If you're having trouble finding Valtrex in stock at your local pharmacy, medfinder can help — we call pharmacies near you to find which ones have your medication in stock and text you the results. Don't let a temporary pharmacy stockout delay treatment that needs to start today.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards